Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

Background: Pathologic complete response (pCR) after neoadjuvant treatment (NAT) is prognostic for recurrence-free survival (RFS) and overall survival (OS) in breast cancer (BC). We assessed prognostic factors for RFS and OS in patients with pCR compared to residual disease (RD) in HER2+ and triple-...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Chiara Corti, Tianyu Li, Alyssa R. Martin, Melissa E. Hughes, Tonia Parker, Tyzaire S. Duporte, Giuseppe Curigliano, Tari A. King, Elizabeth A. Mittendorf, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2026-06-01
סדרה:	Breast
נושאים:	Breast cancer Neoadjuvant Triple negative HER2 Pathologic response Outcomes
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S0960977626000755
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!